Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply.

Komaki Y, Yamada A, Komaki F, Sakuraba A. Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply. Aliment Pharmacol Ther. 2017 11; 46(9):905-906.

View in: PubMed

collapse authors with profiles